Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2003
07/16/2003CN1429550A Matrine enteric coatel tablet and its preparation method
07/16/2003CN1429549A Matrine capsule and its preparation method
07/16/2003CN1114604C Bicyclic aryl carboxamides and their therapeutic use
07/16/2003CN1114597C Quinoline derivs
07/16/2003CN1114440C Medicine for treating toothache
07/16/2003CN1114435C Pill for nourishing yin and its preparing process
07/16/2003CN1114434C Medical capsule for treating hepatitis and its preparing process
07/16/2003CN1114433C Medical capsule for invigorating function of spleen and its preparing process
07/16/2003CN1114431C Modicine for treating atrophic gastritis and its preparing process
07/16/2003CN1114428C Medicine for treating hepatobiliary disease and its preparing process
07/16/2003CN1114415C Medicine for curing enteritis and bacillary dy sentery
07/16/2003CN1114405C Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation
07/16/2003CN1114394C Caries-preventive dentifrice composition
07/15/2003US6593472 NK-1 receptor active amine oxide prodrugs
07/15/2003US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis
07/15/2003US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
07/15/2003US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery
07/15/2003US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
07/15/2003US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/15/2003US6593339 Use of compounds as antibacterial agents
07/15/2003US6593336 Methods for treating irritable bowel syndrome
07/15/2003US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's
07/15/2003US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof
07/15/2003US6593322 Compounds and methods for modulation of estrogen receptors
07/15/2003US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue
07/15/2003US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization
07/15/2003US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
07/15/2003US6592910 Methods of treating clinical diseases with isoflavones
07/15/2003US6592901 Highly compressible ethylcellulose for tableting
07/15/2003US6592896 Medicinal composition and method of using it
07/15/2003US6592887 Mixture containing water soluble polymer
07/15/2003US6592860 Composition and applicator for topical substance delivery
07/15/2003CA2262269C Treatment of skeletal disorders
07/15/2003CA2245938C Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
07/15/2003CA2180843C Pyridine modulators of acetylcholine receptors
07/15/2003CA2067408C 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
07/10/2003WO2003056013A1 TGF-β-SPECIFIC COVALENTLY CLOSED ANTISENSE MOLECULE
07/10/2003WO2003056012A1 A system for stable expression of sirnas in mammalian cells
07/10/2003WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses
07/10/2003WO2003055992A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003WO2003055987A1 Novel lactobacillus sp. strain and use thereof
07/10/2003WO2003055984A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
07/10/2003WO2003055918A1 Negatively charged polysaccharide derivable from aloe vera
07/10/2003WO2003055916A2 Adiponectin fragments and conjugates
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055881A1 Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors
07/10/2003WO2003055880A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055865A1 Quinazolinone derivative
07/10/2003WO2003055863A1 Novel alkansulfonamides as endothelin antagonists
07/10/2003WO2003055529A1 Dna vaccine for periodontal disease
07/10/2003WO2003055483A1 Famotidine injection
07/10/2003WO2003055481A1 Organ fibrosis inhibitors
07/10/2003WO2003055474A1 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003050119A3 Urea substituted imidazopyridines
07/10/2003WO2003011227A3 Taste masking composition
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2002100354A8 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
07/10/2003WO2001089549A3 Therapeutic uses of il-1 receptor antagonist
07/10/2003WO2001089364A9 Hcv variants
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis.
07/10/2003US20030130495 G-protein coupled receptors, signal transduction pathways
07/10/2003US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130325 Substituted tryptophan derivatives
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130304 Preventive or therapeutic agents for gastric or esophageal regurgitation
07/10/2003US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130283 CRF receptor antagonists and methods relating thereto
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130281 DPP IV inhibitors
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130268 Mixture containing water soluble polymer and surfactant; antiinflammatory agents, antiulcer agents, Crohn's disease
07/10/2003US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
07/10/2003US20030130260 Aryl fused azapolycyclic compounds
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents
07/10/2003US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
07/10/2003US20030130229 Pharmaceutical compositions including alginates and methods of preparing and using same
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130168 Reverse-turn mimetics and methods relating thereto
1 ... 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 ... 1258